Previous studies confirmed that overexpression of SPHK1 was associated with decreased expression of E-cadherin and increased expression of vimentin, suggesting that SPHK1 plays a pivotal role in the EMT of invasive carcinoma cells [19, 38, 61]. Here, VIM is linked to invasive carcinoma.